Complement component C3 — Drug Target

All drugs that target Complement component C3 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Complement C3 inhibitor

Phase 2 pipeline (1)

• APL2 · Apellis Pharmaceuticals, Inc. · Complement C3 inhibitor · Immunology
  APL2 is a complement C3 inhibitor that blocks the central component of the complement cascade to reduce inflammation and tissue damage.